Protein Interaction Networks Link Schizophrenia Risk Loci to Synaptic Function

Schizophrenia is a severe and highly heritable psychiatric disorder affecting approximately 1% of the population. Genome-wide association studies have identified 108 independent genetic loci with genome-wide significance but their functional importance has yet to be elucidated. Here, we develop a novel strategy based on network analysis of protein–protein interactions (PPI) to infer biological function associated with variants most strongly linked to illness risk. We show that the schizophrenia loci are strongly linked to synaptic transmission (P FWE < .001) and ion transmembrane transport (P FWE = .03), but not to ontological categories previously found to be shared across psychiatric illnesses. We demonstrate that brain expression of risk-linked genes within the identified processes is strongly modulated during birth and identify a set of synaptic genes consistently changed across multiple brain regions of adult schizophrenia patients. These results suggest synaptic function as a developmentally determined schizophrenia process supported by the illness’s most associated genetic variants and their PPI networks. The implicated genes may be valuable targets for mechanistic experiments and future drug development approaches.

[1]  Paul Pavlidis,et al.  Assessing identity, redundancy and confounds in Gene Ontology annotations over time , 2013, Bioinform..

[2]  Steven R. Head,et al.  Molecular profiles of schizophrenia in the CNS at different stages of illness , 2008, Brain Research.

[3]  Jesse Gillis,et al.  Genome-wide expression profiling of schizophrenia using a large combined cohort , 2011, Molecular Psychiatry.

[4]  M. McCarthy,et al.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.

[5]  I. Melle,et al.  Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium , 2016, Molecular Psychiatry.

[6]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[7]  B. Bogerts,et al.  Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited. , 2014, JAMA psychiatry.

[8]  Pat Levitt,et al.  Molecular Evidence for Increased Expression of Genes Related to Immune and Chaperone Function in the Prefrontal Cortex in Schizophrenia , 2007, Biological Psychiatry.

[9]  P. Andersen,et al.  Effects of family history and place and season of birth on the risk of schizophrenia. , 1999, The New England journal of medicine.

[10]  Karl J. Friston,et al.  Synaptic Plasticity and Dysconnection in Schizophrenia , 2006, Biological Psychiatry.

[11]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[12]  Ayellet V. Segrè,et al.  Common Inherited Variation in Mitochondrial Genes Is Not Enriched for Associations with Type 2 Diabetes or Related Glycemic Traits , 2010, PLoS genetics.

[13]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[14]  R. Hoffman,et al.  Schizophrenia as a disorder of developmentally reduced synaptic connectivity. , 2000, Archives of general psychiatry.

[15]  D. Lewis,et al.  Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry , 2011, International Journal of Developmental Neuroscience.

[16]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[17]  C. Furlanello,et al.  Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes , 2010, The Pharmacogenomics Journal.

[18]  Peter B. Jones,et al.  Disease-relevant autoantibodies in first episode schizophrenia , 2010, Journal of Neurology.

[19]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[20]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[21]  D. Lewis,et al.  Dendritic spine pathology in schizophrenia , 2013, Neuroscience.

[22]  R. Balice-Gordon,et al.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis , 2011, The Lancet Neurology.

[23]  Josep Dalmau,et al.  Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma , 2007, Annals of neurology.

[24]  R. Sweet,et al.  Dendritic spine alterations in schizophrenia , 2015, Neuroscience Letters.

[25]  Alejandro Hernández,et al.  Hidden prenatal malnutrition in the rat: role of β1‐adrenoceptors on synaptic plasticity in the frontal cortex , 2011, Journal of neurochemistry.

[26]  Tyrone D. Cannon,et al.  Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort. , 2000, The American journal of psychiatry.

[27]  Tyrone D. Cannon,et al.  Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. , 2008, Schizophrenia bulletin.

[28]  Eric S. Lander,et al.  A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.

[29]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[30]  S. Hirsch,et al.  Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[31]  M. Skalej,et al.  Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. , 2013, JAMA psychiatry.

[32]  D. Lewis,et al.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.

[33]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[34]  C. Davies,et al.  Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia , 2011, Journal of neuroscience research.

[35]  Patrick F. Sullivan,et al.  Genetic architectures of psychiatric disorders: the emerging picture and its implications , 2012, Nature Reviews Genetics.

[36]  H. M. Morris,et al.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.

[37]  Christophe Dessimoz,et al.  Quality of Computationally Inferred Gene Ontology Annotations , 2012, PLoS Comput. Biol..

[38]  C. McKay,et al.  Ketamine abusers presenting to the emergency department: a case series. , 2000, The Journal of emergency medicine.

[39]  Zhongming Zhao,et al.  Protein-protein interaction and pathway analyses of top schizophrenia genes reveal schizophrenia susceptibility genes converge on common molecular networks and enrichment of nucleosome (chromatin) assembly genes in schizophrenia susceptibility loci. , 2014, Schizophrenia bulletin.

[40]  M. McCarthy,et al.  Interrogating Type 2 Diabetes Genome-Wide Association Data Using a Biological Pathway-Based Approach , 2009, Diabetes.

[41]  David A Lewis,et al.  Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. , 2005, The American journal of psychiatry.

[42]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[43]  J. Coyle,et al.  Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.

[44]  D. Clair,et al.  Latent Effects of Prenatal Malnutrition on Adult Health , 2008, Annals of the New York Academy of Sciences.

[45]  Danko D. Georgiev,et al.  Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. , 2014, The American journal of psychiatry.

[46]  Laura J. Scott,et al.  Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways , 2015, Nature Neuroscience.

[47]  Peter B. Jones,et al.  Obstetric complications and schizophrenia: historical and meta-analytic review. , 2002, The American journal of psychiatry.

[48]  Victor Vostrikov,et al.  Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. , 2004, The American journal of psychiatry.

[49]  Simon C. Potter,et al.  Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia , 2013, Nature Genetics.

[50]  G. Feng,et al.  Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. , 2012, Annual review of neuroscience.

[51]  Xiaoyu Peng,et al.  Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis , 2010, The Journal of Neuroscience.

[52]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[53]  Chunyu Liu,et al.  Two Gene Co-expression Modules Differentiate Psychotics and Controls , 2012, Molecular Psychiatry.

[54]  M. Barnes,et al.  Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function , 2009, Molecular Psychiatry.

[55]  T. Giger,et al.  The Cerebral Microvasculature in Schizophrenia: A Laser Capture Microdissection Study , 2008, PloS one.

[56]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[57]  J. Pierri,et al.  Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia , 1999, Biological Psychiatry.